PEACE-3 is a strong example of how academic cooperative research can help advance progress for complex diseases such as metastatic prostate cancer
Asahi Kasei is consistently pursuing its strategy of building a focused, sustainable specialty pharmaceutical platform for immunocompromised and medically complex patient groups
The MoU lays the groundwork for deep academic and research collaboration in pharmaceutical technologies
Prostate cancer is one of the fastest-growing cancers in India, with approximately 37,948 new cases each year
Our vision is to position India not just as a consumer of advanced simulation technologies but as a creator and exporter of them
This approval builds on the recent transformation RYBREVANT FASPRO brought to lung cancer care
The VELO system supports multiplex testing for Influenza A, Influenza B, and COVID-19, producing PCR results in six to ten minutes
This transaction fundamentally strengthens Scinai's CDMO platform
The enhancements will improve environmental sustainability, strengthen material governance, and boost utility reliability
Subscribe To Our Newsletter & Stay Updated
